Metabolic Synergy 4X

Description

The Metabolic Synergy 4X Research Kit combines SG-1 (Semaglutide, 30mg), RT-3 (Retatrutide, 30mg), Cagrilintide (10mg), and SS-31 (10mg) — a comprehensive metabolic research panel spanning GLP-1R agonism, triple incretin receptor activation, amylin signaling, and mitochondrial protection.

Kit Components

• SG-1 / Semaglutide: GLP-1R agonist — appetite suppression, insulin potentiation, POMC activation.
• RT-3 / Retatrutide: Triple GLP-1R/GIPR/GCGR co-agonist — the most potent weight loss and hepatic steatosis reduction agent in clinical investigation.
• Cagrilintide: Long-acting amylin analogue — complementary satiety via AMY1/2/3 receptor pathways.
• SS-31 (Elamipretide): Mitochondria-targeted cardiolipin-binding peptide — ETC supercomplex stabilization, ROS reduction, and mitochondrial ATP efficiency improvement.

Research Context

This kit addresses metabolic research at three levels: peripheral satiety hormone pharmacology (semaglutide, cagrilintide), maximal multi-receptor metabolic activation (retatrutide), and the mitochondrial bioenergetics that ultimately determine the cellular response to improved metabolic signaling (SS-31). Together they enable researchers to study the full pathway from receptor activation to cellular energy outcomes.

Common Research Applications

• Comprehensive multi-pathway metabolic biology research
• GLP-1/GIP/GCG/amylin pathway combination studies
• Metabolic + mitochondrial synergy investigation
• NASH/obesity multi-mechanism pathway research

For Research Use Only. Not for human or veterinary use.